QEMISTRY-Dementia
Quantifying and Explaining Mortality associated with psychotropic prescribing in dementia
Research Team
- Juan Carlos Bazo Alvarez (Lead Researcher)
- Martin Knapp
- Frank Arrojo
- Jane Ward
- Nathan Davies
- Irene Petersen
- Claudia Cooper
- Sube Banerjee
Lead Institution
Partners
- London School of Economics and Political Science
- University of Nottingham
- Queen Mary University of London
Funded by the NIHR Three Schools Dementia Research Programme
Up to one in four people-with-dementia are prescribed antipsychotic drugs annually. This is for behaviours that are challenging to them or others, such as agitation or aggression, or for psychosis. In psychosis, a person might see or hear things that others can’t or have unusual ideas or beliefs.
Fifteen years ago, researchers found that people-with-dementia were twice as likely to die from taking antipsychotic drugs as people without dementia. A government report found that 1 in a 100 died because they were prescribed antipsychotics. After a warning in 2009 by the medicine and health regulator, antipsychotic prescribing nearly halved.
To make prescribing safer, those who write prescriptions are asked to check blood pressure and heart rhythm, and do blood tests before starting treatment, and check for side-effects regularly. They are advised to prescribe at the lowest doses for the shortest time possible. But we found that people-with-dementia take antipsychotics for an average of six months – longer than recommended. Worryingly, people from minority ethnic groups and women were prescribed for longer than other groups.
You may also be interested in
-
Understanding Needs Assessments for People Living with Dementia
Project dates: 01/09/2026 – 31/03/2027 Research Team Joseph Webb Lucy Series Jon Symonds Gail Gregory John Hyde David Wilkins Becky Oatley Kay Libby Luke Geoghegan Richard Orson Hannah Scaife Lead Institution Adult social care assessments are a critical meeting to determine whether a person requires support with daily…
-
Dementia Risk Prediction in Primary Care in Areas of Socioeconomic Deprivation
Stakeholder perspectives on dementia risk prediction tools in primary care in areas of socioeconomic deprivation
-
Use of ICT by carers of people living with dementia (CareTek)
What ICT do carers find useful, what benefits to they get from using ICT and what support with ICT would they value?